Format

Send to

Choose Destination
See comment in PubMed Commons below
Wien Med Wochenschr. 2013 Nov;163(21-22):477-94. doi: 10.1007/s10354-013-0239-8. Epub 2013 Oct 1.

[Current diagnostic requirements in chronic myeloid leukemia].

[Article in German]

Author information

1
LabDia Labordiagnostik/St.Anna Kinderkrebsforschung, Zimmermannplatz 8, 1090, Wien, Österreich, Thomas.Lion@labdia.at.

Abstract

In patients with chronic myeloid leukemia, high-quality diagnostics is of paramount importance for the surveillance of treatment efficacy. The availability of new tyrosine kinase inhibitors providing more rapid and deeper responses requires the employment of standardized and highly sensitive diagnostic methods to ensure optimal monitoring of the patients. This review presents the current international diagnostic standards and the certified laboratories in Austria.

PMID:
24081749
DOI:
10.1007/s10354-013-0239-8
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center